Clinical Trial Update: Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nerve growth factor eye drops in retinitis pigmentosa with cystoid macular edema completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystoid Macular Edema
• Retinitis Pigmentosa

Snippet

Sponsor: Ospedale San Raffaele | Conditions: Retinitis Pigmentosa, Cystoid Macular Edema | Phase 2 | Status: COMPLETED